Trust Co. of Vermont Sells 1,065 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Trust Co. of Vermont lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 34.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,045 shares of the exchange traded fund’s stock after selling 1,065 shares during the period. Trust Co. of Vermont’s holdings in SPDR S&P Biotech ETF were worth $183,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in XBI. Concourse Financial Group Securities Inc. lifted its position in SPDR S&P Biotech ETF by 21.2% during the fourth quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock valued at $59,000 after purchasing an additional 115 shares during the period. Verity Asset Management Inc. grew its position in SPDR S&P Biotech ETF by 0.8% during the fourth quarter. Verity Asset Management Inc. now owns 17,368 shares of the exchange traded fund’s stock valued at $1,551,000 after buying an additional 140 shares during the period. Greenwich Wealth Management LLC grew its position in shares of SPDR S&P Biotech ETF by 1.4% during the 4th quarter. Greenwich Wealth Management LLC now owns 11,451 shares of the exchange traded fund’s stock valued at $1,022,000 after acquiring an additional 155 shares during the period. Mesirow Institutional Investment Management Inc. grew its holdings in SPDR S&P Biotech ETF by 3.2% during the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 5,565 shares of the exchange traded fund’s stock valued at $497,000 after purchasing an additional 170 shares during the period. Finally, HB Wealth Management LLC increased its holdings in SPDR S&P Biotech ETF by 4.9% in the 4th quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock worth $382,000 after acquiring an additional 200 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 1.3 %

NYSEARCA XBI opened at $90.59 on Tuesday. The stock has a market cap of $6.90 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The company’s 50 day moving average is $89.10 and its two-hundred day moving average is $89.98.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.